Abstract
With the rise in obesity and bariatric procedures worldwide, there has been a surge in new and innovative procedures that has been increasingly offered to patients. In this position statement, IFSO highlights the importance of surgical ethics in innovation and when offering new procedures. Furthermore, the task force reviewed the current literature to describe which procedures can be offered as mainstream outside research protocols versus those that are still investigational and need further data.
Similar content being viewed by others
Change history
22 August 2022
A Correction to this paper has been published: https://doi.org/10.1007/s11695-022-06249-9
References
Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31(5):1937–1948. https://doi.org/10.1007/s11695-020-05207-7.
Cardenas D. Surgical ethics: a framework for surgeons, patients, and society. Rev Col Bras Cir. 2020;15(47):e20202519. https://doi.org/10.1590/0100-6991e-20202519.
Angelos P. Ethics and surgical innovation: challenges to the professionalism of surgeons. Int J Surg. 2013;11(Suppl 1):S2-5. https://doi.org/10.1016/S1743-9191(13)60003-5.
The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. Ethical Principles and Guidelines for the Protection of Human subjects or Research. https://www.hhs.gov/ohrp/regulations-and-policy.
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194.
Levine RJ. New international ethical guidelines for research involving human subjects. Ann Intern Med. 1993;119:340–51.
Health & Medicine, Technology, Business, Oct 25, 2011
Enfield KB, Truwit JD. The purpose, composition, and function of an institutional review board: balancing priorities. Respir Care. 2008;53(10):1330–6.
Lapid MI, Clarke BL, Wright RS. Institutional Review Boards: what clinician researchers need to know. Mayo Clin Proc. 2019;94(3):515–25. https://doi.org/10.1016/j.mayocp.2019.01.020.
Blenkinsopp A. From compliance to concordance: how are we doing? Int J Pharm Pract. 2001;9:65–6.
Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651–61.
Raper SE, Sarwer DB. Informed consent issues in the conduct of bariatric surgery. Surg Obes Relat Dis. 2008;4(1):60–8.
Wee Ch C, Pratt JS. Fanelli R, Samour PQ, Trainor LS, Paasche‐Orlow MK. Best practice updates for informed consent and patient education in weight loss surgery. Obesity. 2012;17(5): 885–888
Kaufman AS, McNelis J, Slevin M, La Marca C. Bariatric surgery claims—a medico-legal perspective. Obes Surg. 2006;16:1555–8.
Heerman WJ, White RO, Barkin SL. Advancing informed consent for vulnerable populations. Pediatrics. 2015;135(3):e562–4. https://doi.org/10.1542/peds.2014-3041.
Weithorn LA, Campbell SB. The competency of children and adolescents to make informed treatment decisions. Child Dev. 1982;53:1589–98.
Kuther TL, Posada M. Children and adolescents' capacity to provide informed consent for participation in research. Adv Psychol Res. 2004;32:163–173. https://www.surgeons.org/about-racs/positionpapers/interactions_with_the_medical_industry_2017.
Royal Australasian College of Surgeons, Australian Safety and Efficacy Register of New Interventional Procedures – Surgical.
The Practice Committee of the American Society for Reproductive Medicine. Definition of "experimental procedures. Fertil Steril. 2009;92(5):1517.
Ashton CM, Wray NP, Jarman AF, Kolman JM, Wenner DM, Brody BA. Ethics and methods in surgical trials. J Med Ethics. 2009;35(9):579–83. https://doi.org/10.1136/jme.2008.028175.
McCambridge J, Sorhaindo A, Quirk A, Nanchahal K. Patient preferences and performance bias in a weight-loss trial with a usual care arm. Patient Educ Couns. 2014;95(2):243–7. https://doi.org/10.1016/j.pec.2014.01.003.
Broekman ML, Carrière ME, Bredenoord AL. Surgical innovation: the ethical agenda: a systematic review. Medicine (Baltimore). 2016;95(25):e3790. https://doi.org/10.1097/MD.0000000000003790.
Halverson JD, Wise L, Wazna MF, Ballinger WF. Jejunoileal bypass for morbid obesity. A critical appraisal Am J Med. 1978;64:461–75.
Griffen WO Jr, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186(4):500–9.
Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47(6):1345–51.
Abu Dayyeh BK, Edmundowicz S, Thompson CC. Clinical Practice Update: Expert Review on Endoscopic Bariatric Therapies. Gastroenterology. 2017;152(4):716–29.
Brown W.A., Ponce de Leon-Ballesteros G., Ooi G., Higa K., Himpens J., Torres A., Shikora S., Kow L., Herrera M.F. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS). IFSO Position Statement—Update 2020. Obes Surg. 2021.
Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial [published correction appears in Lancet. 2019 Mar 30;393(10178):1298]. Lancet. 2019;393(10178):1299–1309. https://doi.org/10.1016/S0140-6736(19)30475-1
De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement. Obes Surg. 2018;28(5):1188–206.
De Luca M, Piatto G, Merola G, et al. IFSO update position statement on one anastomosis gastric bypass (OAGB). Obes Surg. 2021;31(7):3251–78. https://doi.org/10.1007/s11695-021-05413-x.
Aleman R, Lo Menzo E, Szomstein S, Rosenthal RJ. Efficiency and risks of one-anastomosis gastric bypass. Ann Transl Med. 2020;8(Suppl 1):S7. https://doi.org/10.21037/atm.2020.02.03.
da Silva LE, Alves MM, El-Ajouz TK, Ribeiro PC, Cruz RJ Jr. Laparoscopic Sleeve-Collis-Nissen Gastroplasty: a Safe Alternative for Morbidly Obese Patients with Gastroesophageal Reflux Disease. Obes Surg. 2015;25(7):1217–22. https://doi.org/10.1007/s11695-014-1523-4.
Del Genio G, Tolone S, Gambardella C, Brusciano L, Volpe ML, Gualtieri G, Del Genio F, Docimo L. Sleeve gastrectomy and anterior fundoplication (D-SLEEVE) prevents gastroesophageal reflux in symptomatic GERD. Obes Surg. 2020 May;30(5):1642–52. https://doi.org/10.1007/s11695-020-04427-1 Erratum In: Obes Surg. 2021;31(4):1902.
Crawford C, Gibbens K, Lomelin D, Krause C, Simorov A, Oleynikov D. Sleeve gastrectomy and anti-reflux procedures. Surg Endosc. 2017 Mar;31(3):1012–21. https://doi.org/10.1007/s00464-016-5092-6.
Aiolfi A, Micheletto G, Marin J, Rausa E, Bonitta G, Bona D. Laparoscopic sleeve-fundoplication for morbidly obese patients with gastroesophageal reflux: systematic review and meta-analysis. Obes Surg. 2021;31(4):1714–1721. https://doi.org/10.1007/s11695-020-05189-6.
Carandina S, Zulian V, Nedelcu A, Danan M, Vilallonga R, Nocca D, Nedelcu M. Is it safe to combine a fundoplication to sleeve gastrectomy? Review of literature. Medicina (Kaunas). 2021;57(4):392. https://doi.org/10.3390/medicina57040392.
Khazzaka A, Sarkis R. Fundoplication combined with mediogastric plication. Surg Obes Relat Dis. 2013;9(3):398–403. https://doi.org/10.1016/j.soard.2011.08.019.
Lee WJ, Han ML, Ser KH, Tsou JJ, Chen JC, Lin CH. Laparoscopic Nissen fundoplication with gastric plication as a potential treatment of morbidly obese patients with GERD, first experience and results. Obes Surg. 2014;24(9):1447–52. https://doi.org/10.1007/s11695-014-1223-0.
Talha A, Ibrahim M. Laparoscopic Nissen fundoplication plus mid-gastric plication for treatment of obese patients with gastroesophageal reflux disease. Obes Surg. 2018;28(2):437–43. https://doi.org/10.1007/s11695-017-2862-8.
Ospanov O, Maleckas A, Orekeshova A. Gastric greater curvature plication combined
with Nissen fundoplication in treating gastroesophageal reflux disease and obesity. Medicina (Kaunas). 2016;52(5):283–290. https://doi.org/10.1016/j.medici.2016.08.001.
Ivano FH, Mesquita LP, Simamura CM, Kuwaki GM, Colman JT, Campos GM. Pre and postoperative pH monitoring and weight loss analysis in patients undergoing gastric plication in association with fundoplication. Arq Bras Cir Dig. 2017;30(4):244–247. https://doi.org/10.1590/0102-6720201700040004.
Herron DM. Comment on: fundoplication combined to a medio-gastric plication. Surg Obes Relat Dis. 2013;9(3):403–4. https://doi.org/10.1016/j.soard.2011.09.001.
Santoro S, Castro LC, Velhote MCP, Malzoni CE, Klajner S, Castro LP, Lacombe A, Santo MA, Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256:104–10.
Belicik T. Metabolic effects of sleeve gastrectomy with transit bipartition in obese females with type 2 diabetes mellitus: results after 1 year follow-up. Obes Surg. 2019;29:805–10.
Mui WL-M, Lee DW-H, Lam KK-Y. Laparoscopic sleeve gastrectomy with loop bipartition: a novel metabolic operation in treating obese type II diabetes mellitus. Int J Surg Case Rep. 2014;5:56–8.
Mahdy A, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg. 2016;34:28–34.
Mahdy T, Gado W, Alwahidi A, Schou C, Emile SH. Sleeve gastrectomy, one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity: a retrospective cohort study. Obes Surg. 2021;31:1579–89.
Emile SH, Mahdy T, Schou C, Kramer M, Shikora S. Systematic review of the outcome of single-anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity with proportion meta-analysis of improvement in diabetes mellitus. Int J Surg. 2021;92:104–10.
Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodeno-jejunal bypass: technique and preliminary results. Obes Surg. 2009;19:1341–5.
Seki Y, Kasama K, Umezawa A, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for type 2 diabetes mellitus. Obes Surg. 2016;26(9):2035–44.
Seki Y, Kasama K, haruta H, Watanabe A, Yokoyama R. et al. Five-year-results of laparoscopic sleeve gastrectomy with duodenojejunal bypass for weight loss and type 2 diabetes mellitus. Obes Surg. 2017;3:795–801. https://doi.org/10.1007/s11695-016-2372-0.
Praveen Raj P, Kumaravel R, Chandramaliteeswaran C, Rajpandian S, Palanivelu C. Is laparoscopic duodenojejunal bypass with sleeve an effective alternative to Roux En Y gastric bypass in morbidly obese patients: preliminary results of a randomized trial. Obes Surgery. 2012;22:422–6.
Lee WJ, Almulaifi AM, Tsou J-J, Ser K-H, Lee Y-C, Chen S-C. Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11(4):765–70.
Naitoh T, Kasama K, Seki Y, et al. Efficacy of sleeve gastrectomy with duodenal-jejunal bypass for treating obese severe diabetes patients in Japan: a retrospective multicenter study. Obes Surg. 2018;28(2):497–505.
Melissas J, Peppe A, Askoxilakis J, Dimitriadis E, Grammatikakis J. Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation. Obes Surg. 2012;22(7):1104–9. https://doi.org/10.1007/s11695-012-0637-9.
Hassn A, Luhmann A, Rahmani S, Morris-Stiff G. Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery. Obes Surg. 2016;26(10):2316–23. https://doi.org/10.1007/s11695-016-2098-z.
Singh D, Laya AS, Clarkston WK, Allen MJ. Jejunoileal bypass: a surgery of the past and a review of its complications. World J Gastroenterol. 2009;15(18):2277–9. https://doi.org/10.3748/wjg.15.2277.
Cohen R, Caravatto PP, Petry T. Metabolic surgery for type 2 diabetes in patients with a BMI of <35 kg/m(2): A Surgeon’s Perspective. Obes Surg. 2013;23(6):809–18. https://doi.org/10.1007/s11695-013-0930-2.
DePaula AL, Macedo AL, Mota BR, Schraibman V. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg Endosc. 2009;23(6):1313–20. https://doi.org/10.1007/s00464-008-0156-x.
Celik A, Ugale S, Ofluoglu H, Asci M, Celik BO, Vural E, Aydin M. Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT). Obes Surg. 2015;25(7):1184–90. https://doi.org/10.1007/s11695-014-1518-1
Tinoco A, El-Kadre L, Aquiar L, Tinoco R, Savassi-Rocha P. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35(10):2238–44. https://doi.org/10.1007/s00268-011-1188-2.
de Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal Interposition ("neuroendocrine brake")--pilot study of a new operation. Surg Obes Relat Dis. 2006;2(4):464–7. https://doi.org/10.1016/j.soard.2006.03.005.
Celik A, Cagiltay E, Ugale S, Asci M, Celik BO, Karaca C, Abdul-Ghani M. Diverted sleeve gastrectomy with ileal transposition in overweight, obese, and morbidly obese patients with type 2 diabetes: results of 1-year follow-up. Surg Obes Relat Dis. 2016;12(3):541–549. https://doi.org/10.1016/j.soard.2015.09.027.
Inabnet WB. Comment on: prospective randomized controlled trial comparing 2 versions of laparoscopic ileal Interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m(2). Surg Obes Relat Dis. 2010;6(3):304–5. https://doi.org/10.1016/j.soard.2009.11.005.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed Consent
For this type of study, formal consent is not required.
Conflict of Interest
Miguel Herrera and Lilian Kow do not have any conflict of interests. Ashraf Haddad is a speaker for Medtronic and EZsurg medical. Ricardo V Cohen reports Research Grant, Johnson&Johnson, Research Grant Medtronic, Research Grant, GI Dynamics. Speaker Johnson&Johnson, Medtronic, GI Dynamics, Jansen. SAB: GI Dynamics, NovoNordisk, Bariatek. Scott Shikora is the Editor-in-Chief of Obesity Surgery Journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Haddad, A., Kow, L., Herrera, M.F. et al. Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement. OBES SURG 32, 3217–3230 (2022). https://doi.org/10.1007/s11695-022-06220-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-022-06220-8